Amplify Treatments, Testing and Advancements ETF is a registered fund series of Amplify ETF Trust (series S000082275). Net assets $9.2M as of 2024-06-30.
Showing 15 of 56 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc | — | $955K | 1034.33% |
| First American Government Obli | — | $920K | 995.76% |
| Labcorp Holdings Inc | — | $602K | 651.83% |
| Quest Diagnostics Inc | — | $563K | 609.90% |
| BioNTech SE | — | $463K | 501.64% |
| Moderna Inc | — | $451K | 487.85% |
| Vaxcyte Inc | — | $408K | 441.27% |
| ImmunityBio Inc | — | $406K | 439.72% |
| Bio-Rad Laboratories Inc | — | $370K | 400.41% |
| Zai Lab Ltd | — | $357K | 386.47% |
| Dynavax Technologies Corp | — | $321K | 348.08% |
| Immunocore Holdings PLC | — | $311K | 336.36% |
| QuidelOrtho Corp | — | $305K | 330.57% |
| BioCryst Pharmaceuticals Inc | — | $279K | 302.03% |
| Vir Biotechnology Inc | — | $265K | 286.75% |
| Report date | Net assets |
|---|---|
| 2024-06-30 | $9.2M |
| 2024-03-31 | $11.1M |